Health
Using SARS-CoV-2 epitope to construct a vaccine – News-Medical.Net
A new study published on the preprint server bioRxiv* in August 2020 reports the use of prediction and advanced simulation techniques to identify a novel T cell epitope on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as th…
A new study published on the preprint server bioRxiv* in August 2020 reports the use of prediction and advanced simulation techniques to identify a novel T cell epitope on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as the basis for a customized vaccine with broad-based efficacy.
The SARS-CoV-2 virus infects the human host cell via its interaction with the host cell membrane. The viral envelope is made up of spike protein as well as membrane (M) and envelop…
-
Business18 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News23 hours agoQueenslanders not out of the woods as more storms, heatwave conditions to continue after horror three days
-
Business19 hours agoThis ASX All Ords stock has more than doubled investor’s money since January. Here’s why it’s tipped to surge another 45%!
-
Noosa News20 hours agoEverything To Know About Spilt Milk 2025